Related Experiment Videos
Blood center perspective: defining the ideal platelet concentrate
1Compliance and Quality Assurance Department, Central Indiana Regional Blood Center, Indianapolis 46208, USA.
Journal of Clinical Apheresis
|January 1, 1995
Summary
Meeting the rising demand for platelets requires collaboration among donors, collection centers, and clinicians. The true measure of platelet efficacy is determined by clinical judgment, not just regulatory standards.
Area of Science:
- Transfusion Medicine
- Hematology
Background:
- Increased demand for platelets over the past two decades presents challenges for blood collection centers.
- Ensuring a safe and readily available platelet supply is critical for patient care.
Purpose of the Study:
- To highlight the collaborative nature of defining ideal platelet products for transfusion.
- To emphasize the importance of clinical judgment in evaluating platelet efficacy.
Main Methods:
- Review of current practices and challenges in platelet production.
- Analysis of the roles of various stakeholders including donors, collection centers, transfusion services, hospital administration, clinicians, and patients.
- Examination of the interplay between regulatory standards and clinical efficacy benchmarks.
Main Results:
- Defining the ideal platelet product is a multi-stakeholder process, not solely determined by collection centers.
- Regulatory definitions provide minimum criteria, but are not the ultimate measure of product success.
- Clinical judgment of product efficacy is the most significant standard for evaluating transfusion effectiveness.
Conclusions:
- Effective platelet supply relies on a partnership involving all stakeholders.
- Clinical outcomes and clinician assessment are paramount in defining the success of platelet transfusions.
- Future efforts should focus on aligning regulatory standards with clinically relevant measures of platelet efficacy.